Janus Henderson Group’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$491K Hold
45,000
﹤0.01% 2012
2025
Q4
$582K Hold
45,000
﹤0.01% 1954
2025
Q3
$582K Hold
45,000
﹤0.01% 1935
2025
Q2
$802K Hold
45,000
﹤0.01% 1716
2025
Q1
$848K Sell
45,000
-5,200
-10% -$118K ﹤0.01% 1704
2024
Q4
$1.5M Hold
50,200
﹤0.01% 1469
2024
Q3
$784K Hold
50,200
﹤0.01% 1791
2024
Q2
$858K Sell
50,200
-10,200
-17% -$179K ﹤0.01% 1700
2024
Q1
$943K Buy
60,400
+2
+0% +$29 ﹤0.01% 1675
2023
Q4
$902K Sell
60,398
-125
-0.2% -$1.67K ﹤0.01% 1682
2023
Q3
$977K Buy
60,523
+49,945
+472% +$1.44M ﹤0.01% 1566
2023
Q2
$439K Sell
10,578
-1,166
-10% -$72.4K ﹤0.01% 2051
2023
Q1
$706K Sell
11,744
-14,701
-56% -$1.17M ﹤0.01% 1821
2022
Q4
$1.94M Buy
26,445
+4,297
+19% +$323K ﹤0.01% 1106
2022
Q3
$1.68M Buy
22,148
+9,174
+71% +$716K ﹤0.01% 1383
2022
Q2
$902K Sell
12,974
-1,222
-9% -$92.1K ﹤0.01% 1395
2022
Q1
$1.18M Sell
14,196
-6,037
-30% -$445K ﹤0.01% 1427
2021
Q4
$1.52M Sell
20,233
-36,134
-64% -$3.63M ﹤0.01% 1354
2021
Q3
$6.55M Buy
56,367
+26,625
+90% +$4.03M ﹤0.01% 990
2021
Q2
$6.6M Sell
29,742
-19,519
-40% -$3.8M ﹤0.01% 1004
2021
Q1
$6.51M Buy
49,261
+43,647
+777% +$6.9M ﹤0.01% 970
2020
Q4
$969K Buy
+5,614
New +$768K ﹤0.01% 1206

Other funds holding NVCR